MHRA Class 2 Medicines Recall: MidaBuc – Midazolam (as HCL) 10mg/mL Oromucosal Solution (Eastone Limited)

MHRA Class 2 Medicines Recall: MidaBuc – Midazolam (as HCL) 10mg/mL Oromucosal Solution (Eastone Limited)

February 17, 2021

Class 2 Medicines recall: MidaBuc – Midazolam (as HCL) 10mg/mL Oromucosal Solution (Eastone Limited)

Drug alert number: EL (21) A/04

Date issued: 16th February 2021

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for:

MidaBuc – Midazolam (as HCL) 10mg/mL Oromucosal Solution (Eastone Limited) MS 3297

Eaststone Limited has informed MHRA of an issue related to underfilled or empty bottles for MidaBuc – Midazolam (as HCL) 10mg/mL Oromucosal Solution. The below batch is being recalled.

Batch Number Expiry Date Pack Size First Distributed
ES84553 15 April 2021 5ml 26 April 2019

Advice for healthcare professionals

Stop supplying the above batches immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Full drug alert can be viewed here.

Company contacts for further information

For more information or medical information queries contact Eaststone at specials@eaststone.co.uk or alternatively call 0800 678 3102.



Posted in: ,


More Latest News >

PQS: AMS virtual event now on-demand

Community pharmacy contractors can now access an online recording of the antimicrobial stewardship (AMS) virtual event, which was jointly hosted...

Evaluation of LFD tests

As part of meeting Medicines and Healthcare products Regulatory Agency (MHRA) obligations, the UK Health Security Agency (UKHSA) – of...